![](/img/cover-not-exists.png)
Everolimus plus exemestane as first-line therapy in HR+, HER2−advanced breast cancer in BOLERO-2
Beck, J. Thaddeus, Hortobagyi, Gabriel N., Campone, Mario, Lebrun, Fabienne, Deleu, Ines, Rugo, Hope S., Pistilli, Barbara, Masuda, Norikazu, Hart, Lowell, Melichar, Bohuslav, Dakhil, Shaker, Geberth,Volume:
143
Language:
english
Journal:
Breast Cancer Research and Treatment
DOI:
10.1007/s10549-013-2814-5
Date:
February, 2014
File:
PDF, 341 KB
english, 2014